跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,429 条关于
“ischemia-reperfusion injury”
全部
19,429
临床试验
18,042
药物
56
机构
15
资讯
1,316
去年
Arch Biopartners Doses First Patient in Canada for Phase II Trial of LSALT Peptide in Cardiac Surgery-Associated Acute Kidney Injury
2年前
Arch Biopartners' LSALT Peptide Phase II Trial Approved for Cardiac Surgery-Associated Acute Kidney Injury
去年
Arch Biopartners Initiates Phase II Trial of LSALT Peptide for Cardiac Surgery-Associated Acute Kidney Injury
2年前
Arch Biopartners Receives Ethics Approval for Phase II Trial of LSALT Peptide in Calgary
9个月前
Arch Biopartners Expands Phase II Trial for LSALT Peptide with St. Michael's Hospital Ethics Approval
去年
Arch Biopartners Doses First Patient in Phase II Trial of LSALT Peptide for Cardiac Surgery-Associated Acute Kidney Injury
11个月前
Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Novel Stroke Therapy scp776
6个月前
Arch Biopartners Advances LSALT Peptide Phase II Trial for Cardiac Surgery-Associated Acute Kidney Injury
去年
Arch Biopartners Advances AKI Programs: LSALT Peptide and Cilastatin Trials Progress
去年
Arch Biopartners Doses First Patient in Phase II Trial for Cardiac Surgery-Associated Acute Kidney Injury
第 1 页，共 132 页
上一页
下一页
